The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis

BACKGROUND: Vortioxetine is the first mixed serotonin agonist and antagonist antidepressant approved in the US. We sought to evaluate all published and unpublished data available to determine the efficacy and harms of vortioxetine in adults with major depressive disorder. METHODS: We used a predefin...

Descripción completa

Detalles Bibliográficos
Autores principales: Meeker, Amanda S, Herink, Megan C, Haxby, Dean G, Hartung, Daniel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351824/
https://www.ncbi.nlm.nih.gov/pubmed/25874839
http://dx.doi.org/10.1186/s13643-015-0001-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351824/
https://www.ncbi.nlm.nih.gov/pubmed/25874839
http://dx.doi.org/10.1186/s13643-015-0001-y

Ejemplares similares